Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
Q1 2026 earnings • released • EPS beat +13.15% • Revenue beat +2.77%
See results
MRK:NYSE
Merck & Co Inc
$112.16
+2.73%
(+2.98) 1D
$112.15
-0.01% (-0.0094)
After hours
Closed: May 1, 4:00:34 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
$112.33
High
$114.54
Low
$111.88
Mkt. cap
277.02B
Volume
11.95M
Dividend
3.03%
Quarterly dividend
$0.85
Ex dividend date
Mar 16, 2026
P/E ratio
31.56
52-wk high
$125.14
52-wk low
$73.31
EPS
$3.55
Beta
0.27
Shares outstanding
2.47B
No. of employees
74K
News stories
From sources across the web
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74K
FoundedJan 1, 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Last report
Apr 30, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-1.28/ (-1.47 est.)USD
+13.15%beat
Revenue / Estimate
16.29B/ (15.85B est.)USD
+2.77%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.81B
17.28B
16.40B
16.29B
Cost of goods sold
3.39B
3.74B
4.30B
3.96B
Cost of revenue
3.39B
3.74B
4.30B
3.96B
Research and development expenses
4.00B
4.00B
4.00B
12.56B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.50B
2.48B
2.73B
2.67B
Operating expense
6.49B
6.48B
6.73B
15.23B
Total operating expenses
9.88B
10.23B
11.02B
19.18B
Operating income
5.92B
7.05B
5.38B
-2.90B
Other non operating income
69.00M
-
41.00M
-318.00M
EBT including unusual items
5.00B
6.74B
3.42B
-3.53B
EBT excluding unusual items
5.68B
6.76B
4.98B
-3.22B
Income tax expense
571.00M
958.00M
458.00M
709.00M
Effective tax rate
11.42%
14.20%
13.39%
-20.06%
Other operating expenses
-
-
-
-
Net income
4.43B
5.78B
2.96B
-4.24B
Net profit margin
28.01%
33.49%
18.07%
-26.03%
Earnings per share
2.13
2.58
2.04
-1.28
Interest and investment income
69.00M
96.00M
69.00M
-
Interest expense
-305.00M
-327.00M
-411.00M
-
Net interest expenses
-236.00M
-231.00M
-342.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
6.99B
8.15B
6.79B
-1.74B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer